Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-055983
Filing Date
2024-03-01
Accepted
2024-03-01 16:15:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 37980
2 GRAPHIC g518298g0202154214130.jpg GRAPHIC 2179
3 GRAPHIC g518298g518298dsp5.jpg GRAPHIC 3801
  Complete submission text file 0001193125-24-055983.txt   47618
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)